Clinical Trial Update: Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. [Phase 3]

View source ↗

Summary

A randomized Phase III trial in stage IIIb and IV non-small cell lung cancer compares sequential single-agent, double-agent, and triple-agent therapy; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Aktion Bronchialkarzinom e.V. | Conditions: Non-Small-Cell Lung Carcinoma | Phase 3 | Status: COMPLETED